Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis
Completed
Conditions studied: Multiple Sclerosis, RRMS
In brief
This is a 3-year, pharmacologically non-interventional study to evaluate OCT as an outcome measure in patients with relapsing remitting multiple sclerosis (RRMS). Approximately 350 RRMS patients, either untreated or treated with an approved MS disease-modifying therapy and approximately 70 reference subjects without ophthalmologic or neurologic disease are enrolled. No study medications are provided. Patients on disease-modifying therapy are treated according to the local prescribing information. For each MS patient and each reference subject, the study consists of Screening (up to 1 month), Baseline, and a 36-month longitudinal data collection phase. Eligibility will be confirmed during Screening.
Key facts
- Study ID
- NCT02907281
- Run by
- Novartis Pharmaceuticals
- People needed
- 414
- Starts
- 2012-05-29
- Expected to finish
- 2017-07-24
- Last updated by the study team
- 2017-11-17
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — San Francisco, California, United States
- Novartis Investigative Site — Torrance, California, United States
- Novartis Investigative Site — Iowa City, Iowa, United States
- Novartis Investigative Site — Baltimore, Maryland, United States
- Novartis Investigative Site — Philadelphia, Pennsylvania, United States
- Novartis Investigative Site — Camperdown, New South Wales, Australia
- Novartis Investigative Site — Parkville, Victoria, Australia
- Novartis Investigative Site — Calgary, Alberta, Canada
- Novartis Investigative Site — Greenfield Park, Quebec, Canada
- Novartis Investigative Site — Prague, Czechia
- Novartis Investigative Site — Copenhagen, Denmark
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Magdeburg, Germany
- Novartis Investigative Site — Cagliari, CA, Italy
- Novartis Investigative Site — Milan, MI, Italy
- Novartis Investigative Site — Bari, Italy
- Novartis Investigative Site — Genova, Italy
- Novartis Investigative Site — Montichiari, Italy
- Novartis Investigative Site — Padova, Italy
- Novartis Investigative Site — Roma, Italy
- Novartis Investigative Site — Amsterdam, Netherlands
- Novartis Investigative Site — Lodz, Lódzkie, Poland
- Novartis Investigative Site — Barcelona, Catalonia, Spain
- Novartis Investigative Site — Barcelona, Catalonia, Spain
- Novartis Investigative Site — Valencia, Valencia, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.